Humacyte Inc. (NASDAQ: HUMA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT HUMACYTE INC.

Humacyte Inc. (NASDAQ: HUMA)
Listen to this Section


$1.37
-0.1250 ( -8.39% ) 4.7M

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

Clinical Trial Pipeline Stages


Drug Name Stage
Human Acellular Vessel (HAV)DetailsDialysis access (AV access) Phase 3
Humacyte Acellular Tissue Engineered Vessel (ATEV™)DetailsDialysis access (AV access) Phase 3

Market Data


Open $1.37
Previous Close $1.49
Volume 4.7M
Market Cap $310.83M
Day Range $1.36 - $1.52
52 Week Range $0.55 - $2.93
Shares Outstanding 222.02M
Change % -8.39%
Net Change ▼ -0.1250
Insider Ownership -0.25%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2021
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -11,429,032.00

Date Type Amount Purchased Purchaser
2025-04-15 Buy 6493.00 Scheessele William John
2025-04-14 Buy 7500.00 Parikh Shamik J
2025-04-14 Buy 20000.00 Sander Dale A.
2025-04-08 Buy 50000.00 Sebelius Kathleen
2025-04-08 Buy 16000.00 Constantino Michael T.
2025-04-08 Buy 6000.00 Green Charles Bruce
2024-12-04 Buy 4600.00 Constantino Michael T.
2024-11-21 Buy 1797.00 Dougan Brady W
2024-11-21 Buy 1797.00 Niklason Laura E
2024-09-03 Buy 1222.00 Niklason Laura E

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Jun 11, 2025

Latest News


× Before browsing our site, please accept our cookies policy